Documentary Chronicles Record Run for a Departed Friend and Myeloma Research
A new documentary, “200 Miles,” tells the inspiring story of ultra-marathoner Eric Gelber’s determination to complete 33 loops of New York’s Central Park to…
News
Switzerland Grants PharmaMar’s Aplidin Orphan Drug Status to Treat Multiple Myeloma
Switzerland’s Agency for Therapeutic Products (Swissmedic) has awarded PharmaMar’s Aplidin orphan drug status to treat patients with multiple myeloma, following a similar designation by the U.S. Food…
One World Cannabis to Test Mice in Pursuit of Therapies Targeting Multiple Myeloma Cancer Cells
Israel’s One World Cannabis (OWC) says it’s moving forward to mouse models to test its unique formula of cannabinoid-based therapies targeting cancer cells. This decision followed promising results…
Darzalex Approved in Europe as Combo Therapy for Advanced Multiple Myeloma
Janssen’s Darzalex (daratumumab) received full approval by the European Commission (EC) for use in treating adult patients with multiple myeloma who have received at least…
GMI-1271 Restores Velcade’s Punch Against Myeloma in Mice, Study Reports
GlycoMimetics’ GMI-1271 restored the punch of the myeloma treatment Velcade (bortezomib) in mice, which should rekindle hope in patients who failed to respond to…
Phase 1 Actimab-M Trial at Baylor Recruiting Heavily Treated Myeloma Patients
Multiple myeloma patients who received at least three prior lines of therapy and whose cancer expresses the CD33 molecule may enroll in the recently opened…
Janssen to Discuss New Combinations of Darzalex and Other Multiple Myeloma Therapies
Janssen Biotech will discuss at a Chicago cancer conference the effectiveness of new multiple myeloma treatment combinations that include its therapy Darzalex (daratumumab). The…
Multiple Myeloma Marathon Runner Don Wright, 76, Races Again in Philadelphia
Don Wright, the 76-year-old marathon runner who recently reached his goal of running 100 marathons after being diagnosed with multiple myeloma, ran Philadelphia’s Miles for…
Microfluidic Device May Replace Bone Marrow Biopsies for Myeloma
Patients with multiple myeloma soon may be diagnosed and followed solely with the use of a blood sample, avoiding the painful process of collecting a…
FDA Grants Tasquinimod Orphan Drug Status to Treat Multiple Myeloma
The small molecule immunomodulatory drug tasquinimod has been designated an orphan drug by the U.S. Food and Drug Administration (FDA) for the treatment of multiple…
Recent Posts
- Treatment before surgery slows PDAC disease progression: Study
- Scientists discover tissue differences in brain cancer in children
- Elahere approved in EU as treatment for ovarian cancer
- Survival better with Blenrep combo than Darzalex for R/R myeloma
- Aucatzyl, a cell therapy, approved in US for adults with advanced B-ALL